
Explore complete financial details, shareholding patterns, and trade unlisted shares securely.
Current Offer Price
Anglo-French Drugs & Industries Limited (AFDIL), incorporated in 1923 and headquartered in Bengaluru, is a long-established pharmaceutical company engaged in the manufacturing of synthetic pharmaceutical products and healthcare formulations. The company produces a diversified range of products including vitamins, anti-epileptics, antioxidants, cough and cold medicines, digestive enzymes, calcium supplements, protein food supplements, and sleep-inducing formulations, serving both domestic and international markets. With nearly a century of operating history, AFDIL benefits from strong industry experience, an established product portfolio, and an experienced management team. Its long-standing presence in the pharmaceutical sector supports brand credibility and operational stability in the healthcare industry.
| Anglo-French Drugs & Industries Limited Price | ₹0.00 Per Equity Share |
| Lot Size | 0 Shares |
| 52 Week High | 0 Shares |
| 52 Week Low | 0 Shares |
| Depository | 0 |
| PAN Number | AAACA9756E |
| ISIN Number | 0 |
| CIN | L24230KA1923PLC010205 |
| RTA | Canbank Computer Services |
| Market Cap (in Cr.) | 0.00 |
| P/E Ratio | 0.00 |
| P/B Ratio | 0.00 |
| D/E Ratio | 0.15 |
| ROE | 6.39 |
| Book Value | 1195.84 |
| Face Value | 10.00 |
| Total Shares | 1130000 |
| Field | 2023 | 2024 | 2025 |
|---|---|---|---|
| da | 3.3 | 3 | 3 |
| eps | 1480.62 | -97.56 | 70.8 |
| npm | 185.44 | -12.63 | 9.09 |
| opm | -39.32 | -11.58 | -18.75 |
| pat | 191 | -12 | 8 |
| pbt | 251 | -12 | 8 |
| tax | 60 | 0 | 0 |
| ebit | -43.8 | -14 | -19.5 |
| ebitda | -40.5 | -11 | -16.5 |
| revenue | 103 | 95 | 88 |
| pbt margins | 243.69 | -12.63 | 9.09 |
| ebit margins | -42.52 | -14.74 | -22.16 |
| finance cost | 3 | 2 | 2 |
| other income | 299 | 5 | 30 |
| gross margins | 24.76 | 28.42 | -0.5 |
| other expenses | 43 | 19 | 19 |
| change in inventory | 9.5 | -2 | 23.3 |
| cost of material consumed | 68 | 70 | 68 |
| employee benefit expenses | 23 | 19 | 18 |